GSA Capital Partners LLP Has $1.05 Million Stock Position in Integer Holdings Co. (NYSE:ITGR)

GSA Capital Partners LLP cut its stake in Integer Holdings Co. (NYSE:ITGR) by 58.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,101 shares of the medical equipment provider’s stock after selling 11,173 shares during the period. GSA Capital Partners LLP’s holdings in Integer were worth $1,053,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ITGR. Versor Investments LP grew its position in Integer by 48.0% in the third quarter. Versor Investments LP now owns 3,404 shares of the medical equipment provider’s stock valued at $443,000 after acquiring an additional 1,104 shares during the period. State of New Jersey Common Pension Fund D grew its holdings in shares of Integer by 1.8% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 15,582 shares of the medical equipment provider’s stock worth $2,026,000 after purchasing an additional 268 shares during the last quarter. Crossmark Global Holdings Inc. increased its position in shares of Integer by 14.7% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,899 shares of the medical equipment provider’s stock worth $377,000 after purchasing an additional 372 shares in the last quarter. Legacy Capital Wealth Partners LLC lifted its holdings in Integer by 92.1% during the 3rd quarter. Legacy Capital Wealth Partners LLC now owns 3,688 shares of the medical equipment provider’s stock valued at $479,000 after purchasing an additional 1,768 shares during the last quarter. Finally, Portside Wealth Group LLC acquired a new position in Integer in the third quarter valued at about $356,000. Institutional investors own 99.29% of the company’s stock.

Integer Price Performance

Integer stock opened at $133.22 on Friday. The stock has a market cap of $4.47 billion, a price-to-earnings ratio of 41.13, a P/E/G ratio of 1.98 and a beta of 1.09. Integer Holdings Co. has a 12-month low of $84.75 and a 12-month high of $140.91. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The business’s 50-day simple moving average is $129.12 and its 200 day simple moving average is $122.46.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter in the previous year, the company earned $1.27 EPS. Integer’s revenue was up 8.7% on a year-over-year basis. As a group, research analysts anticipate that Integer Holdings Co. will post 5.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on ITGR shares. Bank of America lifted their target price on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Benchmark lifted their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. Piper Sandler restated an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Truist Financial cut their price target on Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Citigroup raised their price objective on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $139.75.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.